US 10088485
Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand
granted A61KA61K31/00A61K31/427
Quick answer
US patent 10088485 (Methods of screening compounds that can modulate NR2F6 by displacement of a reference ligand) held by Regen Biopharma, Inc. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regen Biopharma, Inc.
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/00, A61K31/427, A61K31/7088